WTVD

Moderna vaccine remains 93% effective against symptomatic COVID at 6 months, company says

Moderna says its vaccine is 93% effective against symptomatic illness at six months (though this data collection ended before delta emerged in the U.S.). Moderna said its booster candidates also ...
FOX 5 Atlanta

Moderna: Vaccine 93% effective up to 6 months but booster likely needed before winter

CAMBRIDGE, Mass. - Moderna’s COVID-19 vaccine remained 93% effective against symptomatic illness six months after the second dose, but amid the ongoing spread of the highly contagious delta variant, ...

This stock is already up 58% this year. Is it a buy?

This forgotten pandemic stock hasn't said its last word.
WGN Radio

Moderna vaccine remains 90 percent effective after 6 months, company says

(NEXSTAR) – The Moderna COVID-19 remains effective even after 6 months, the company said in a Tuesday update on its ongoing clinical trials. The study looked at 33 healthy adult participants in the ...
Hosted on MSN

Experimental Moderna flu shot more effective than approved vaccine, company says

Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the company’s mRNA-1010 flu vaccine’s efficacy was nearly 27 percent higher for ...
The Business Journals

Trial of Moderna’s flu vaccine proves more effective than standard-dose shot in trial

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Cambridge drug and vaccine ...